Ajanta Pharma Ltd share price logo

Ajanta Pharma Share Price

NSE: AJANTPHARM

BSE: 532331

Mid Cap

Healthcare Sector

₹2949.20

+10.80

(+0.37%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Ajanta Pharma Stock Performance

as on January 2, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹2,902.8
    ₹3,020.8
    downward going graph

    1.57%

    Downside

    2.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹2,327.3
    ₹3,094.25
    downward going graph

    21.09%

    Downside

    4.92%

    Upside

    downward going graph

Ajanta Pharma share price movements today

Previous Close
₹2,938.40
Open
₹2,937.00
Volume
2.89L
Upper Circuit
₹3,526.00
Lower Circuit
₹2,350.80
Day's Low - High
₹2,902.8 - ₹3,020.8
52 Week Low - High
₹2,327.3 - ₹3,094.25

Ajanta Pharma Historical Returns

1 Month Return
+ 13.14 %
3 Month Return
+ 22.79 %
1 Year Return
+ 2.63 %
3 Year Return
+ 145.67 %
5 Year Return
+ 168.14 %

Ajanta Pharma Fundamentals

as on January 2, 2026 at 4:01 pm IST

Market Cap

₹36,846.01 Cr

Return on Equity (ROE)

26.05

PE Ratio (TTM)

37.87

Return on capital employed (ROCE)

32.78

Industry PE ratio

41.74

Beta (LTM)

0.74

P/B Ratio

9.05

Dividend Yield

1.07

PEG Ratio

4.57

Quarterly Earnings Growth YOY

20.19

EPS (TTM)

73.43

Sector

Pharmaceuticals

Book Value

302.38

Technical Analysis

Bullish

View Technical Analysis

Ajanta Pharma Stock Valuation

as on January 2, 2026 at 4:01 pm IST

Ajanta Pharma in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (37.87x)

January 2, 2026

Industry (41.74x)

January 2, 2026

Highest (50.52x)

September 10, 2024

LowHigh

Today’s Price to Earnings Ratio: 37.87x

Ajanta Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ajanta Pharma Ltd image
Ajanta Pharma Ltd
BUY36,846.0133.63%0.529204,648
Sanofi India Ltd image
Sanofi India Ltd
BUY9,538.57-10.05%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY70,590.635.17%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD92,261.5917.7%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY59,765.6315.9%0.001,4146,445
See all

Analyst Recommendation on Ajanta Pharma Stock

Based on 13 analysts

BUY

76.92%

Buy

7.69%

Hold

15.38%

Sell

Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Ajanta Pharma. Average target price of ₹2988.62

Source: S&P Global Market Intelligence

Ajanta Pharma Share Price Target

Get share price movements and forecasts by analysts on Ajanta Pharma.

What analysts predicted

1.34%UPSIDE

Target Price

₹2988.62

Current Price

₹2949.2

Analyzed by

13 Analysts

High

₹3293

Target

₹2988.62

Low

₹2450

Ajanta Pharma target price ₹2988.62, a slight upside of 1.34% compared to current price of ₹2949.2. According to 13 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Stock’s Investor Sentiment and Interest

Investment in Ajanta Pharma Ltd Shares on INDmoney has grown by 339.74% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:339.74% versus previous 30 day period

Search interest for Ajanta Pharma Ltd Stock has increased by 116% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:116% versus previous 30 day period

Ajanta Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
881.84
1,021.04
1,028.44
1,105.15
1,054.08
1,144.92
1,186.64
1,146.13
1,170.41
1,302.65
1,353.73
Other Income
36.83
31.75
21.33
13.59
35.5
26.47
19.48
30.44
18.11
26.33
59.34
Total Income
918.67
1,052.79
1,049.77
1,118.74
1,089.58
1,171.39
1,206.12
1,176.57
1,188.52
1,328.98
1,413.07
Expenses
732.47
749.72
737.78
791.08
775.76
814.57
875.47
825.3
873.26
951.3
1,025.9
Operating Profit
149.37
271.32
290.66
314.07
278.32
330.35
311.17
320.83
297.15
351.35
327.83
Operating Profit Margin %
16.94%
26.57%
28.26%
28.42%
26.4%
28.85%
26.22%
27.99%
25.39%
26.97%
24.22%
Profit Before Interest, Tax and Depreciation
186.2
303.07
311.99
327.66
313.82
356.82
330.65
351.27
315.26
377.68
387.17
Interest
1.13
0.85
2.34
2.49
1.53
0.73
6.02
7.91
6.07
5.26
3.39
Depreciation
33.02
33.18
33.71
34.26
34.25
33.97
34.39
35.97
39.78
41.29
42.97
Profit Before Tax
152.05
269.04
275.94
290.91
278.04
322.12
290.24
307.39
269.41
331.13
340.81
Tax Paid
29.8
60.92
80.64
80.88
75.32
76.35
73.76
74.51
44.15
75.79
80.62
Profit After Tax
122.25
208.12
195.3
210.03
202.72
245.77
216.48
232.88
225.26
255.34
260.19
Total Net profit including share of profit / Loss from associate company
122.25
208.12
195.3
210.03
202.72
245.77
216.48
232.88
225.26
255.34
260.19
EPS
9.54
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
20.83
Actual EPS
9.54
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
20.83
Adjusted EPS
9.54
16.53
15.51
16.68
16.1
19.54
17.27
18.6
18
20.44
20.83
Diluted EPS
9.54
16.53
15.5
16.67
16.09
19.53
17.26
18.59
18
20.43
20.82

Ajanta Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,001.64
2,130.86
2,055.37
2,587.87
2,889.69
3,340.99
3,742.64
4,208.71
4,648.1
Other Income
23.86
24.16
21.08
92.19
25.98
115.68
98.64
84.6
94.5
Total Income
2,025.5
2,155.02
2,076.45
2,680.06
2,915.67
3,456.67
3,841.28
4,293.31
4,742.6
Expenses
1,314.76
1,472.47
1,488.94
1,908.46
1,891.13
2,411.69
2,959.39
3,036.77
3,388.6
Operating Profit
686.88
658.39
566.43
679.41
998.56
929.3
783.25
1,171.94
1,259.5
Operating Profit Margin %
34.32%
30.9%
27.56%
26.25%
34.56%
27.82%
20.93%
27.85%
27.1%
Profit Before Interest, Tax and Depreciation
710.74
682.55
587.51
771.6
1,024.54
1,044.98
881.89
1,256.54
1,354
Interest
1.36
0.41
1.16
11.91
8.27
10.2
5.84
7.21
20.73
Depreciation
61.21
59.59
72.08
95.72
116.09
125.3
130.8
135.4
144.11
Profit Before Tax
648.17
622.55
514.27
663.97
900.18
909.48
745.25
1,113.93
1,189.16
Tax Paid
141.34
153.91
127.3
196.27
246.31
196.8
157.27
297.76
268.77
Profit After Tax
506.83
468.64
386.97
467.7
653.87
712.68
587.98
816.17
920.39
Total Net profit including share of profit / Loss from associate company
506.83
468.64
386.97
467.7
653.87
712.68
587.98
816.17
920.39
EPS
57.59
53.26
43.97
53.6
75.09
54.97
49.89
64.82
73.56
Actual EPS
57.59
53.26
43.97
53.6
75.09
54.97
49.89
64.82
73.56
Adjusted EPS
38.39
35.51
29.31
35.73
50.06
36.65
49.89
64.82
73.56
Diluted EPS
57.58
53.25
43.96
53.6
75.09
54.96
45.89
64.77
73.33

Ajanta Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
326.15
609.29
281.12
374.51
456.77
576.31
561.71
792.11
785.07
1,157.23
Cash Flow from Investing Activities
88.86
-84.01
6.6
120.19
15.02
-110.77
74.74
-385.11
217.8
-58.6
Cash Flow from Financing Activities
-117.32
-201.77
-0.2
-147.46
-128.63
-318.29
-459.71
-108.2
-1,051.06
-733.41
Net Cash Flow
-0.23
24.4
24.81
4.27
103.74
-24.36
27.9
124.31
-200.6
47.3

Ajanta Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Apr 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
66.11%
66.21%
66.21%
66.21%
66.21%
66.21%
66.27%
66.26%
66.26%
66.26%
66.26%
66.25%
DII
15.98%
16.02%
14.7%
14.91%
16.01%
17.49%
17.41%
17.1%
17.02%
17.48%
17.5%
17.9%
FII
0%
0%
0%
0%
0%
8.54%
8.36%
9.11%
9.26%
8.86%
8.86%
8.53%
Government
0%
0%
0%
0%
0%
0%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
7.91%
7.74%
7.78%
8.2%
8.01%
7.76%
7.94%
7.52%
7.45%
7.39%
7.38%
7.32%
Total Outstanding Shares
12,81,25,155
12,59,14,655
12,59,15,655
12,59,15,655
12,59,15,655
12,59,15,655
12,48,87,774
12,49,12,099
12,49,12,099
12,49,12,099
12,49,12,099
12,49,35,624
Total Shareholders
83,549
56,939
54,874
56,277
54,351
55,488
70,316
64,315
66,896
70,827
68,882
67,785

Mutual Funds that own Ajanta Pharma Stock

Check out the Mutual Funds with significant holdings in Ajanta Pharma.

Ajanta Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Ajanta Pharma.

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 20.19% since last year same period to ₹260.19Cr in the Q2 2025-2026. On a quarterly growth basis, Ajanta Pharma Ltd has generated 1.9% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Ajanta Pharma Ltd Dividends November,2025

    In the quarter ending September 2025, Ajanta Pharma Ltd has declared dividend of ₹28.00 per share on 03 Nov 2025 - translating a dividend yield of 0.95%.

    Read More about Dividends

Indices Featuring Ajanta Pharma Stock

Check stock indices that include Ajanta Pharma.

BSE Healthcare

₹44,057.70

0.74 (▲322.7%)

Nifty LargeMidcap 250

₹17,043.75

0.85 (▲143.2%)

Nifty Midcap 150

₹22,579.05

0.94 (▲209.9%)

Nifty MidSmallcap 400

₹20,443.85

0.88 (▲178.35%)

NIFTY PHARMA

₹22,790.90

0.7 (▲158.15%)

S&P BSE 400 MidSmallCap

₹12,278.39

0.89 (▲108.04%)

Nifty 500

₹24,099.00

0.79 (▲189.45%)

BSE Mid-Cap

₹47,539.18

0.97 (▲457.57%)

BSE 500

₹37,799.57

0.81 (▲302.47%)

S&P BSE 250 LargeMidCap

₹11,299.00

0.8 (▲90.22%)

S&P BSE 150 MidCap

₹16,641.08

0.92 (▲151.49%)

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 1.17K Cr → 1.41K Cr (in ₹), with an average increase of 5.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 225.26 Cr → 260.19 Cr (in ₹), with an average increase of 6.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AJANTPHARM stock has moved up by 9.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 14.2% return, outperforming this stock by 11.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 151.5% return, outperforming this stock by 5.8%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 66.26% to 66.25% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 8.86% to 8.53% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.38% to 7.32% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 14.72% to 14.67% in Sep 2025 quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,353.73Cr as on September 2025 (Q2 FY26)
Net Profit: ₹260.19Cr as on September 2025 (Q2 FY26)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
IndustryPharmaceuticals
CEOMannalal B Agrawal
E-voting on sharesClick here to vote

FAQs

What is Ajanta Pharma share price today?

Ajanta Pharma share price today stands at ₹2949.2 as on at the close of the market. Ajanta Pharma share today touched a day high of ₹3020.8 and a low of ₹2902.8.

What is the 52 week high and 52 week low range for Ajanta Pharma share?

Ajanta Pharma touched a 52 week high of ₹3094.25 and a 52 week low of ₹2327.3. Ajanta Pharma share price today i.e. is closed at ₹2949.2, which is -4.69% down from its 52 week high and 26.72% up from its 52 week low.

What is Ajanta Pharma's market capitalisation today?

Ajanta Pharma market capitalisation is ₹36,846.01 Cr as on .

How to buy Ajanta Pharma shares?

To buy Ajanta Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AJANTPHARM or Ajanta Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ajanta Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ajanta Pharma trading volume today?

Ajanta Pharma trading volume is 2.89L as on . This means that 2.89L shares of Ajanta Pharma were bought and sold on the stock market during today's trading session.